Response to the Comment on "Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve"
- PMID: 33605595
- DOI: 10.1097/SLA.0000000000004788
Response to the Comment on "Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve"
Conflict of interest statement
The authors report no conflicts of interest.
Comment on
-
Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve.Ann Surg. 2022 Apr 1;275(4):759-768. doi: 10.1097/SLA.0000000000004054. Ann Surg. 2022. PMID: 33055587
-
Comment on "Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve".Ann Surg. 2021 Dec 1;274(6):e882-e884. doi: 10.1097/SLA.0000000000004789. Ann Surg. 2021. PMID: 33605593 No abstract available.
References
-
- Reames BN, Ejaz A, Weiss MJ. Comment on “Arterial resection in pancreatic cancer surgery: effective after a learning curve”. Ann Surg 2020.
-
- Loos M, Kester T, Klaiber U, et al. Arterial resection in pancreatic cancer surgery: effective after a learning curve. Ann Surg 2020; doi:10.1097/SLA.0000000000004054. [Epub ahead of print]. - DOI
-
- Hackert T, Sachsenmaier M, Hinz U, et al. Locally advanced pancreatic cancer: neoadjuvant therapy with Folfirinox results in resectability in 60% of the patients. Ann Surg 2016; 264:457–463.
-
- Klaiber U, Schnaidt ES, Hinz U, et al. Prognostic factors of survival after neoadjuvant treatment and resection for initially unresectable pancreatic cancer. Ann Surg 2021; 273:154–162.
-
- Neoptolemos JP, Dunn JA, Stocken DD, et al. For the members of the European Study Group for Pancreatic Cancer (ESPAC). Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 2001; 358:1576–1585.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical